Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Consolidated Balance Sheets (Unaudited)

v3.21.2
Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Jun. 30, 2021
Dec. 31, 2020
Current assets    
Cash and cash equivalents $ 343,733 $ 272,092
Short-term deposits 179,000 27,000
Accounts receivable, net of allowance for credit losses of $0.8 million and $0.9 million as of June 30, 2021 and December 31, 2020 109,969 106,068
Inventories 124,227 131,672
Prepaid expenses 7,288 6,717
Other current assets 21,189 16,943
Total current assets 785,406 560,492
Non-current assets    
Property, plant and equipment, net 201,080 201,232
Goodwill 39,686 35,694
Other intangible assets, net 124,257 131,569
Operating lease right-of-use assets 17,514 21,298
Other non-current assets 55,081 39,717
Total non-current assets 437,618 429,510
Total assets 1,223,024 990,002
Current liabilities    
Accounts payable 42,001 16,987
Accrued expenses and other current liabilities 30,134 31,061
Accrued compensation and related benefits 29,270 25,659
Deferred revenues - short term 48,943 49,165
Operating lease liabilities - short term 8,248 9,282
Total current liabilities 158,596 132,154
Non-current liabilities    
Deferred revenues - long term 15,661 14,227
Operating lease liabilities - long term 9,553 12,567
Contingent consideration 40,436 37,400
Other non-current liabilities 37,206 34,059
Total non-current liabilities 102,856 98,253
Total liabilities 261,452 230,407
Contingencies (see note 12)
Redeemable non-controlling interests 227 227
Equity    
Ordinary shares, NIS 0.01 nominal value, authorized 180,000 thousand shares; 65,396 thousand shares and 56,617 thousand shares issued and outstanding at June 30, 2021 and December 31, 2020, respectively 181 155
Additional paid-in capital 2,992,833 2,753,955
Accumulated other comprehensive loss (6,703) (8,846)
Accumulated deficit (2,024,966) (1,985,896)
Total equity 961,345 759,368
Total liabilities and equity $ 1,223,024 $ 990,002